AndHealth Plus

Macuject Selected for AndHealth+ Award

Macuject has been selected as a recipient of the highly competitive AndHealth+ award for 2022.

Five digital health companies will benefit from in $5m in funding to accelerate commercialisation of their platforms.

The funding will be used to generate real-world evidence, finalise commercial models, advance regulatory approval and progress toward commercial launch.

For more information, please visit the following page:

Just click the button and we’ll contact with you in the next few hours

Request a demo